CRP and metabolic dysfunction-associated steatotic liver disease: They observed, in an interesting way, that NAFLD was even an independent predictor of lower C-reactive protein levels and a higher rate of the remission of disease (OR, 2.57; 95% CI, 1.21–5.80), suggesting almost a hypothetical protective role of NAFLD in CD patients.